Brokerages Set Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Price Target at $70.22

Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHCGet Free Report) have been assigned an average rating of “Moderate Buy” from the nine ratings firms that are currently covering the stock, MarketBeat.com reports. Two analysts have rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average twelve-month price objective among brokerages that have issued ratings on the stock in the last year is $70.22.

Several analysts recently commented on ACHC shares. Cantor Fitzgerald reiterated a “neutral” rating and issued a $52.00 target price on shares of Acadia Healthcare in a report on Tuesday, December 10th. Barclays reduced their price objective on shares of Acadia Healthcare from $76.00 to $43.00 and set an “overweight” rating on the stock in a research note on Friday, November 22nd. TD Cowen dropped their target price on shares of Acadia Healthcare from $70.00 to $66.00 and set a “buy” rating on the stock in a report on Tuesday, January 7th. Deutsche Bank Aktiengesellschaft upgraded Acadia Healthcare from a “hold” rating to a “buy” rating and increased their price target for the stock from $45.00 to $75.00 in a report on Thursday, December 12th. Finally, StockNews.com downgraded Acadia Healthcare from a “hold” rating to a “sell” rating in a research note on Monday, January 6th.

View Our Latest Stock Report on Acadia Healthcare

Acadia Healthcare Stock Performance

NASDAQ:ACHC opened at $44.18 on Tuesday. The stock’s 50-day moving average is $41.15 and its 200-day moving average is $56.37. The stock has a market cap of $4.10 billion, a P/E ratio of 14.49, a price-to-earnings-growth ratio of 1.79 and a beta of 1.29. Acadia Healthcare has a 1-year low of $36.50 and a 1-year high of $87.77. The company has a current ratio of 1.07, a quick ratio of 1.07 and a debt-to-equity ratio of 0.60.

Acadia Healthcare (NASDAQ:ACHCGet Free Report) last released its quarterly earnings results on Wednesday, October 30th. The company reported $0.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.90 by $0.01. The firm had revenue of $815.60 million during the quarter, compared to the consensus estimate of $819.42 million. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The company’s revenue for the quarter was up 8.7% on a year-over-year basis. During the same quarter last year, the firm earned $0.91 earnings per share. Equities research analysts anticipate that Acadia Healthcare will post 3.39 earnings per share for the current year.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the company. abrdn plc lifted its position in shares of Acadia Healthcare by 61.4% during the 4th quarter. abrdn plc now owns 157,293 shares of the company’s stock worth $6,237,000 after buying an additional 59,824 shares in the last quarter. Pacer Advisors Inc. lifted its holdings in Acadia Healthcare by 2.4% during the fourth quarter. Pacer Advisors Inc. now owns 13,847 shares of the company’s stock worth $549,000 after acquiring an additional 325 shares during the period. KBC Group NV boosted its position in Acadia Healthcare by 50.1% in the fourth quarter. KBC Group NV now owns 4,035 shares of the company’s stock worth $160,000 after purchasing an additional 1,347 shares during the last quarter. Blue Trust Inc. grew its stake in Acadia Healthcare by 69.4% in the 4th quarter. Blue Trust Inc. now owns 842 shares of the company’s stock valued at $33,000 after purchasing an additional 345 shares during the period. Finally, Fifth Third Bancorp raised its stake in shares of Acadia Healthcare by 56.0% during the 4th quarter. Fifth Third Bancorp now owns 1,264 shares of the company’s stock worth $50,000 after purchasing an additional 454 shares during the period.

About Acadia Healthcare

(Get Free Report

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.

See Also

Analyst Recommendations for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.